Neurological implications of urea cycle disorders

Area of Science:

• Biochemistry
• Neuroscience
• Genetics

Background:

• Urea cycle disorders (UCDs) are rare genetic conditions impairing ammonia detoxification.
• Hyperammonaemia, a consequence of UCDs, causes severe central nervous system dysfunction.
• Both acute and chronic hyperammonaemia induce significant alterations in neurotransmitter systems.

Purpose of the Study:

• To review the neurological consequences of hyperammonaemia in UCDs.
• To explore current and emerging therapeutic strategies for UCDs.
• To highlight the potential of neuroprotective interventions.

Main Methods:

• Review of existing literature on UCDs, hyperammonaemia, and neurological effects.
• Analysis of neuropathological findings and neuroimaging markers (e.g., 1H MRS).
• Evaluation of therapeutic approaches, including ammonia-lowering agents and neuroprotection.

Main Results:

• Acute hyperammonaemia causes excitotoxicity via NMDA receptor activation and astrocyte dysfunction.
• Chronic hyperammonaemia leads to adaptive changes in NMDA receptors and the glutamate-nitric oxide-cGMP pathway, affecting cognition.
• Neuroimaging can detect metabolic alterations like elevated glutamine and reduced myoinositol.

Conclusions:

• Hyperammonaemia profoundly impacts brain function through distinct mechanisms in acute and chronic settings.
• While ammonia-lowering agents are standard, neuroprotective strategies offer new therapeutic avenues.
• Targeting pathways like cGMP with phosphodiesterase inhibitors may restore cognitive functions in UCDs.